Latest News
US small business optimism creeps forward in April
Small business optimism improved throughout the month of April, increasing by 1. 7 points to 103. 5, with one index component falling, another unchanged and the remaining eight improving.
Barclays initiates coverage on Meggitt at 'underweight'
Analysts at Barclays initiated coverage on engineering outfit Meggitt on Tuesday, hitting the firm with an 'underweight' rating and 460p target price straight out of the gate.
ITE Group's strong growth powered by turnaround programme
ITE Group on Tuesday reported strong interim profit and revenue growth as its turnaround programme and acquisitions spurred improvements.
Tuesday broker round-up
Jupiter Fund Management: Shore Capital Markets downgrades to hold with a target price of 380p.
Europe midday: Stocks extend early bounce
Stocks are extending their bounce with investors reacting to the more dovish sounding headlines on Tuesday around the intensifying US-China trade conflict, even as analysts and policymakers try to gauge the potential downside for stocks from a protracted commercial dispute between the two economic giants.
Vodafone cuts dividend, full-year EBITDA as expected
Vodafone rebased its full-year dividend to €0. 09 from €0. 15 for the 2018 fiscal year, implying a final dividend of €0. 04, even as it announced its decision to go live with its 5G technology in the UK from 3 July.
Jury orders Bayer to pay couple in excess of $2bn over cancer claims
A jury in California ordered Monsanto-owner, Bayer, to pay over $2bn to a couple who got cancer after using the Roundup weedkiller, in the third and largest verdict against the company over diseases claims.
Asia report: Markets broadly lower as trade war concerns deepen
Asian markets closed largely lower on Tuesday after China retaliated against the latest round of US tariffs by announcing that it will slap tariffs on $60bn-worth of American goods starting from 1 June.
Cellcast cuts losses and reviews options amid falling revenue
Cellcast's shares jumped on Tuesday as the company cut its annual loss on the back of lower costs, though the group is reviewing its prospects as operating revenues dipped and the interactive broadcast business declined.
Nissan warns on full-year profits
Nissan warned on Tuesday that operating profit would fall to the lowest level in 11 years for the fiscal year to March 2020 as it takes a hit partly from the arrest of former chairman Carlos Ghosn.
Stock Spirits swings to interim profit, announces Czech acquisition
Stock Spirits said on Tuesday that it swung to an interim profit as it announced the acquisition of a premium spirits business in the Czech Republic.
US pre-open: Futures point to positive start following rout in previous session
Wall Street futures were pointing to a positive start to trading on Tuesday after the major US stock market indices tumbled during the previous session after China announced its plans to raise tariffs on $60bn-worth of US imports on 1 June.
Trump wages war of words after Beijing ups tariffs
Donald Trump continued his war of words with China on Tuesday, with a series of tweets claiming tariffs had rebuilt America’s steel industry and criticising Beijing for walking away from a deal.
Brent futures jump after drone attack against Saudi pipeline
Crude oil futures popped higher on Tuesday after the Saudi energy minister said that oil installations in the east of the country had been attacked by armed drones and reiterated a call to action against Iranian-backed Houthi rebels in Yemen.
London midday: Stocks extend gains as UK unemployment rate drops, wage growth slows
London stocks had extended gains by midday on Tuesday as investors digested UK jobs data and the latest developments in the Sino-US trade spat.
Eden Research reaches key milestones after gaining several regulatory clearances
Biopesticide developer Eden Research reached several key milestones and made good progress with the commercialisation and regulatory clearance of its products over the last twelve months.
Roche extends offer period in $4.3bn Spark takeover
Switzerland’s Roche has been forced to extend the its $4. 3bn offer for gene specialist Spark Therapeutics as US regulators continue to scrutinise the proposed takeover.
AorTech revenues grow as group adopts new strategy
Polymers developer AorTech saw revenues increase in a trading year that saw it adopt a new strategy, successfully conclude a fundraising and strengthen its board.
First-quarter profits beat forecasts at Allianz
Allianz reiterated full-year targets on Tuesday after the German insurer saw first-quarter net profits nudge ahead.
Portmeirion warns on profits following mixed start to the year
Pottery outfit Portmeirion warned on full-year profits on Tuesday after some mixed trading in the first four months of the year, with good sales growth in its two largest markets being offset by a weaker than expected performance from its Korean operations.